PGX for Pharmacists: Recent Episodes
Pharmacy Podcast Network
This podcast is all about the Pharmacist leveraging the power of Pharmacogenomics. PGX for Pharmacists is a member of the Pharmacy Podcast Network. Pharmacogenomics is the study of the role of the genome in drug response. Its name (pharmaco- + genomics) reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics (drug absorption, distribution, metabolism, and elimination) and pharmacodynamics (effects mediated through a drug's biological targets).
Dr. Lucas Berenbrok is a pharmacist educator and researcher at the University of Pittsburgh School of Pharmacy in Pittsburgh, Pennsylvania. He co-led the implementation of outpatient pharmacogenomic services at University of Pittsburg Medical Center. This unique service, called Primary Care Precision Medicine, provides pharmacogenetic and genetic testing to patients in local and surrounding areas. With his colleagues at the University of Pittsburgh, Berenbrok co-created Test2LearnTM, a pharmacogenomics certificate program for pharmacists. Dr. Neda Leonard, CEO of Rx Gene IQ and she is a Dual Board-Certified Pharmacist in Pharmacotherapy and Geriatrics. She has experience in various setting such as Program for All-inclusive Care for Elderly (PACE) where she uses her expertise in medication management and PGx. She is a seasoned speaker locally and nationally on various subject matters such as pharmacogenomics and polypharmacy. She has published in Drug Metabolism Reviews and was featured in THE CONSULTANT PHARMCIST Journal. Currently she partners with a group of Geriatricians/Internal Medicine physicians using a collaborative practice agreement for patients living independently, in assisted living facilities or in skilled nursing facilities. She has many tools in her toolbox to use such as pharmacogenomics, deprescribing, geriatric medication optimization, Part D Comprehensive Medication Management (CMR) and Targeted Medication Review (TMR),and working with various private insurances such as United Healthcare and Optum.
A Multidisciplinary Precision Medicine Service in Primary Care www.ncbi.nlm.nih.gov/pmc/articles/PMC8786423/ Learn more about your ad choices. Visit megaphone.fm/adchoices
Dr. Larry Shapiro is a clinical psychologist that started back in 1990 but quote on quote retired to become a financial advisor. He was having a discussion with his brother one day, who was a career officer in the Army, returning from Afghanistan. That make Dr. Shapiro to re-think about his contributions to his community, so he got his license back, trained in military trauma, and started again as a psychologist in 2014. He started at St. Louis Behavioral Medicine Institute specializing in treatment of OCD, panic disorder, social anxiety disorder, simple phobias, depression, and combat trauma. Last year he attended the annual Boston Trauma Conference and heard for the first time about the use of psychedelic medicines for treatment of trauma. So after a 150 hour certification program at Integrative Psychiatry Institute he became certified in psychedelic-assisted psychotherapy which now is part of his current practice. Just this year in January he went into private practice so he can focus more on psychedelics. He is also an adjunct instructor in the department of psychiatry at Washington University in St. Louis and a clinical consultant for psilocybin research at Healthy Minds Lab at Washington University. Post-traumatic stress disorder (PTSD) which is one of the most common psychiatric disorders which affects about 8 million adults at some point in their lifetime in the United States. But it is not clear as to why only some people who experience a traumatic event develop PTSD. Some people say it’s a social construct but in the largest and most diverse genetic study of PTSD to date, scientists from University of California San Diego School of Medicine and more than 130 additional institutions participating in the Psychiatric Genomics Consortium found that PTSD has a strong genetic component similar to other psychiatric disorders. Genetics seem to accounts for between 5 and 20 percent of the variability in PTSD risk following a traumatic event.
Resources: https://health.ucsd.edu/news/releases/Pages/2019-10-08-study-reveals-ptsd-has-strong-genetic-component.aspx Learn more about your ad choices. Visit megaphone.fm/adchoices
Significant challenges to widescale clinical implementation of PGx include a lack of physician experience using PGx test data or confidence in interpreting PGx test data and integrating the data into the medication therapy management process. For PGx to be most impactful, prescribers must consider PGx data within the context of other non-genetic patient-specific factors. Pharmacists may help prescribers with PGx test data by creating a summary of medication therapy management recommendations for the patient that streamlines PGx report flags and identifies other pharmacotherapy interventions the pharmacist recognizes while applying non-genetic patient-specific data to the PGx test data.
In this episode of the PGx for Pharmacists podcast, Dr. Becky Winslow discusses the research study, "Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation," with two of the research investigators, Dr. Anna Langerveld and Dr. David Bright. Dr. Langerveld and Dr. Bright share how this research adds to the growing evidence that clinical pharmacists can help improve the utility of PGx and prescribing. They also share how their study described a process for reducing PGx laboratory report information to a single page of patient-specific clinical recommendations. Lastly, they share that while clinical decision support tools are becoming more routine for pharmacogenomic management, the pharmacists in this study reduced the number of report-based alerts independent of sophisticated clinical decision support informatics.
Anna Langerveld, Ph.D., is the Founder and President of Genemarkers, a contract research organization and CLIA/CAP certified testing laboratory specializing in genomics. Anna received her B.A. in Psychology from SUNY Binghamton and her Ph.D. from the Interdisciplinary Program in Neurosciences at Tulane University. After receiving her Ph.D., Anna served as a Research Assistant Professor at Western Michigan University. She founded Genemarkers in 2008. Under her leadership, Michigan Celebrates Small Business recognized the Company as one of the Top 50 Michigan Companies to watch. Anna is an author of peer-reviewed publications, an NIH grant recipient, and an invited speaker at a wide range of national meetings. Anna currently serves as an adjunct professor and an advisory board member for the Manchester University pharmacogenomics program and holds a community faculty position at the Western Michigan University Homer Stryker M.D. School of Medicine. Anna has been instrumental in developing strategic community partnerships to implement the use of genomics in clinical care, with a particular focus on mental health and underserved populations.
Dr. David Bright is a Professor of Pharmacy at Ferris State University, where he has taught therapeutics and medication therapy management. He received his PharmD degree from the University of Toledo, completed a community pharmacy residency with Kroger Pharmacy and the University of Toledo, and served on the faculty at the Ohio Northern University as a community pharmacy residency program director. His research has primarily involved the pragmatic implementation and improvement of non-dispensing pharmacy services, particularly in the outpatient setting. Most recently, that has involved the integration of pharmacogenomics into clinical practice through community pharmacy and ambulatory care practice models.
Research discussed in the podcast episode: Bright D, Saadeh C, DeVuyst-Miller S, Sohn M, Choker A, Langerveld A. Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation. Pharmgenomics Pers Med. 2020 Dec 10;13:719-724. doi: 10.2147/PGPM.S276687. PMID: 33328756; PMCID: PMC7735940. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735940/ Learn more about your ad choices. Visit megaphone.fm/adchoices
Dr. Sandra Awaida is a clinical pharmacist that has been practicing in the US since 1999. She worked as an attending pharmacist at the Massachusetts General hospital which is a Harvard Medical School teaching hospital in the intensive care unit and internal medicine department where she also served on the pharmacy residency advisory committee, the MGH pharmacy research committee and a writer to the MGH pharmacy newsletter. She joined Novartis Canada working on new product launches, developing medical content and speaking on national meetings. Her passion for clinical pharmacy led her on to teach at several universities in the US and abroad until she found her calling when she founded a private cardiology practice where she incorporated Chronic Care Management, Remote Patient Monitoring or RPM and PGx. She is the founder of PreciGenX, LLC. Since 2008, she has worked to advance the non traditional role of pharmacists in medical practices and is a is a huge advocate of a preventative approach to patient care. She is constantly looking to create value by marrying cutting-edge innovative services with the highest evidence-based medicine to achieve the best outcome for her patients and increase ROI or Return of Investment for physicians. And of course she has been mentoring and coaching others to be able to do the same. Learn more about your ad choices. Visit megaphone.fm/adchoices
Camille Schrier, Miss America 2020 is currently pursuing her Pharmacy degree at Virginia Commonwealth University in Richmond. She completed a dual Bachelor of Science degrees in Biochemistry and systems biology. Camille blew up the onstage talent competition with a highly engaging and entertaining version of the “catalytic decomposition of hydrogen peroxide,” Ok let me repeat that. catalytic decomposition of hydrogen peroxide, and that won her Miss Virginia in June of 2019 and then Miss America in December 2019 live on NBC. While competing for the job, Camille wanted it known that “Miss America can be a scientist and a scientist can be Miss America.” She is not only the first woman to win the title using science as a talent, but also as the only Miss America to speak in the General Assembly of the UN, to become grounded by a global pandemic, and be asked to serve for two full years as a direct result of COVID-19. Since then Camille has focused on advocating for her social initiative which is called “Mind Your Meds: Drug Safety and Abuse Prevention from Pediatrics to Geriatrics” with a major focus on the opioid epidemic, as well as for exciting youth in the areas of STEM. Just last year, Camille launched her own science educational brand called “Her Royal Scientist”, which furthers her goal to inspire and educate youth and normalize females in science roles. She also works to raise awareness of the genetic condition that impacts her life, Ehlers Danlos Syndrome Learn more about your ad choices. Visit megaphone.fm/adchoices
In recognition of National Adverse Drug Event Awareness Day, March 24, 2022, Dr. Becky Winslow, CEO of inGENEious RX Precision Medicine Consultants, and Dr. Behnaz Sarrami, PGx Medical Science Liaison of Missouri Pharmacogenomics Consulting, teamed up to cohost a special live episode of the PGx for Pharmacists Podcast.
In this episode, Dr. Winslow and Dr. Sarrami interview Ms. Kristine Ashcraft, STRIPE Steering Committee member; former CEO and founder of YouScript; director of medical affairs at Invitae; a BIS Research recognized top 25 leading voice in precision medicine; and author of multiple publications on both the clinical and economic benefits of PGx testing, and Ms. Rachel Brummert, Special Government Employee (SGE) at the U.S. Food and Drug Administration; contributor at Drugwatch and Medshadow Foundation; and nationally recognized patient safety advocate who has turned the pain she suffered from an adverse drug event into her purpose.
Topics discussed in this episode include:
The financial and clinical costs resulting from adverse drug events' (ADEs) morbidity and mortality.
Pharmacogenomic testing as a tool to mitigate ADEs.
The Right Drug Dose Now Act which was recently introduced by Representatives Swalwell and Emmer and whose intent is to update the Department of Health and Human Services’ National Action Plan for Adverse Drug Event Prevention to include funding for pharmacogenomics testing advocacy. Learn more about your ad choices. Visit megaphone.fm/adchoices
Episode Description: On this episode, Dr. Jeffrey Shaman, Chief Science Officer at Coriell Life Sciences, and I discuss the importance of population health level pharmacogenomics versus one time pharmacogenomics tests and how clinical decision support software that integrates pharmacogenomics data into patients’ medication therapy management is a key tool to optimize population health level pharmacogenomics programs. References: 1. Real-World Impact of a Pharmacogenomics-Enriched Comprehensive Medication Management Program https://www.mdpi.com/2075-4426/12/3/421 2. Idiopathic Symptoms Resolved by Pharmacogenomics-Enriched Comprehensive Medication Management: A Case Report https://www.cureus.com/articles/81096-idiopathic-symptoms-resolved-by-pharmacogenomics-enriched-comprehensive-medication-management-a-case-report 3. Consequences of CYP2D6 Copy-Number Variation for Pharmacogenomics in Psychiatry https://www.coriell.com/resources/consequences-of-cyp2d6-copy-number-variation-for-pharmacogenomics-in-psychiatry/ 4. The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978656/ 5. ASP Establishes March 24th as National Adverse Drug Event Awareness Day https://www.stopadr.org/blog/asp-establishes-march-24-as-national-adverse-drug-event-awareness-day-launches-awareness-campaign Guest’s Bio: Jeffrey A. Shaman, PhD, MS, is the Chief Science Officer at Coriell Life Sciences (CLS), an international leader in precision medicine. Leveraging extensive experience in genetics and pharmacology, he is a leading expert in the rapidly evolving field of pharmacogenomics (PGx), the study of how an individual’s DNA impacts his or her response to medication. Most importantly, Dr. Shaman plays a critical role in bridging the gap between genetic science and clinical application. This includes translating decades of cutting-edge genetic research into actionable insights on the safest and most effective medications for individuals based on their unique DNA and dozens of other factors. Driven to advance public health, Dr. Shaman is focused on enabling the delivery of personalized medicine at scale and empowering the most precise medical care worldwide. He consults with large employers, public and private payer organizations, healthcare systems, academic institutions, and laboratories around the globe, advising them on how to eliminate trial-and-error prescribing, improve population health, and control rising healthcare costs Dr. Shaman is dedicated to setting the industry standard for PGx and pioneering new advancements in the field. Along with his team, he actively researches and presents findings in top peer-reviewed journals and at leading industry events. He is an active member of the Clinical Pharmacogenetics Implementation Consortium (CPIC), Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community, Personalized Medicine Coalition (PMC), Pharmacogenomics Global Research Network (PGRN), and other organizations. Dr. Shaman holds a doctoral degree from The Johns Hopkins University School of Medicine in Pharmacology and Molecular Sciences, where his research centered on DNA, epigenetics, and nuclear structure and function. He earned his Master of Science degree from The University of Medicine and Dentistry of New Jersey in Cell & Developmental Biology. Dr. Shaman held a faculty position at the University of Hawai‘i Institute of Biogenesis Research before serving a fellowship at Harvard Medical School and implementing a translational research program at Beth Israel Deaconess Medical Center and the Bedford Stem Cell Research Foundation. Learn more about your ad choices. Visit megaphone.fm/adchoices
Thanks for joining us today as our host, Dr. Jamie Wilkey talks with a patient, Kristen, who strongly feels that PGx testing saved her life.
Join us for a patient’s side of the story today!
You may reach Kristen at her website: https://www.imnotcrazyproject.org/ her Facebook page: https://www.facebook.com/imnotcrazyproject or on LinkedIn: https://www.linkedin.com/in/kristen-ruth-davis-5540142a/
You may reach Jamie at her website: drjamiewilkey.com or on her LinkedIn page: https://www.linkedin.com/in/dr-jamie-wilkey/
This episode discusses mental health and suicidal ideation. While it is not discussed in great detail, if you are having thoughts of ending your own life we strongly encourage you to push pause and call the National Suicide Prevention Hotline right away at 800-273-8255
References:
IQVIA Institute for Human Data Science. Medicine Use and Spending in the U.S. https://www.iqvia.com/insights/the-iqvia-institute/reports/medicine-use-and-spending-in-the-us-a-review-of-2018-and-outlook-to-2023 Published May 2019. Accessed June 10, 2020.
Spear BB, Heath-Chiozzi M, Hu J. Clinical application of pharmacogenetics. Trends Mol. Med. 2001; 7, 201–204.
Table of Pharmacogenomic Biomarkers in Drug Labeling. U.S. Food and Drug Administration website.: https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labelinghttps://www.fda.gov/Drugs/ScienceResearch/ucm572698.htm Accessed June 10, 2020.
Preventable Adverse Drug Reactions: A Focus on Drug Interactions. U.S. Food and Drug Administration website. www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm110632.htm. Accessed June 10, 2020.
Van Driest SL, Shi Y, Bowton EA, et al. Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing. Clin Pharmacol Ther. 2014; 95(4):423‐431.
Learn more about your ad choices. Visit megaphone.fm/adchoices
According to the American Academy of Family Physicians, there are more than 50 Cytochrome P450 enzymes but there are just 6 of them that metabolize about 90% of the drugs. One of the most significant ones is the CYP2D6. In an article on healio written by Dr. Jai Patel, he talks about CYP2D6 metabolizing many of the SSRIs, SNRIs and TCAs that are the treatment options for depression. The clearance of TCA’s for example is 50-67% lowered in CYP2D6 poor metabolizers compared to normal. www.aafp.org/afp/2007/0801/p391.html Pharmacogenetic testing may improve outcomes for patients with depression (healio.com) Kristine Ashcraft is a molecular biologist by training and is the former CEO and founder of YouScript which was recently acquired by Invitae. She has worked in pharmacogenomics space since 2000 and was recently named one of the 25 leading voices in precision medicine. Kristine has authored multiple publications on both the clinical and economic benefits of PGx testing. She serves on the Steering Committee of STRIPE which is the FDA collaborative community for PGx. She has been interviewed by numerous media including the New York Times, the Wall Street Journal, and NBC Nightly News and has spoken at American Society of Human Genetics, and numerous precision medicine conferences and now speaking at one of the top 20 genomics podcast in the globe, PGx for Pharmacist Podcast. Learn more about your ad choices. Visit megaphone.fm/adchoices
On this episode, Dr. Gillian Bell, a Doctor of Clinical Pharmacy, shares her path from pharmacy school to her non-traditional PharmD job as Pharmacogenomics Lead, Genome Medical. On This Episode We Discuss:
• Gillian’s education (Brief)
• Gillian’s PharmD work experience prior to PGx (Brief) Residency
• Gillian’s PGx work experience prior to Genome Medical (Brief) Mission Hospital
• Brief description of Genome Medical, its mission, its services, its clients
• Gillian’s roles and responsibilities as the Pharmacogenomics Lead at Genome Medical
• What does a typical day at Genome Medical look like for its pharmacists? How do the pharmacists interact with the genetic counselors?
• “Genetic Counseling” or “PGx Inclusive Medication Therapy Management’ do the pharmacists provide one or the other or both? Neither? To whom are the services provided? Providers and/or to patients?
• Gillian’s advice to pharmacists who want to pursue a career in PGx
Learn more about your ad choices. Visit megaphone.fm/adchoices
According to the National Community Pharmacists Association (NCPA), community pharmacists are highly accessible health care professionals and 95% of Americans live within just 5 miles of a pharmacy. (https://ncpa.org/provider-status) And what APhA or American Pharmacist Association, the largest association of pharmacists in the US is doing is laser focusing on getting provider status for pharmacists. So why is that important when it comes to PGx as this is a PGx podcast? Pharmacists can order the PGx test when they see fit for their patients without the need of a clinician to sign that form. Scott Knoer, MS, PharmD, FASHP, became the 13th Executive Vice President and Chief Executive Officer of the American Pharmacists Association in June 2020, after serving for nine years as the Chief Pharmacy Officer at the Cleveland Clinic. Dr. Knoer is a passionate advocate for patients and the profession of pharmacy. He has successfully lobbied boards of pharmacy in Ohio and Minnesota to allow the advancement of pharmacy practice, and he has led initiatives that changed Ohio and federal law related to the elevation of pharmacy practice and reducing the impact of drug shortages. He received his BA in psychology from Creighton University and his PharmD from the University of Nebraska. Learn more about your ad choices. Visit megaphone.fm/adchoices
Pharmacogenomics Market Access and Reimbursement Series Episode Description: Most of us understand that the reimbursement for pharmacogenomics tests has been one barrier amongst many barriers to pharmacogenomics’ wide-scale clinical adoption. Finding myself highly frustrated with the slow clinical uptake by PGx test ordering by healthcare providers back in 2017, I brainstormed about which payers were the most vested in improving patients’ medication outcomes and who would therefore more likely to listen to my pitch about PGX decreasing adverse drug events and increasing therapeutic medication outcomes. As a consultant to self-insured employers who were seeking to lower their employees’ drug spend, I found a warm and receptive audience for pharmacogenomics. It was through my relationships with self-insured employers that I met today’s guest. Again, fate intervened, and today’s guest reached out to me via LinkedIn. She had been following my pharmacogenomics posts and liking what she had seen she introduced me to a group of pharmacists in Kentucky who were integrating PGx into their PBM via comprehensive medication management. Special Guest Jane Cheshire Gilbert, CPA Jane Cheshire Gilbert, CPA Director of Retiree Health Care for the Teachers’ Retirement System of the State of Kentucky Jane has served TRS retirees since April 2002. She manages two retiree health plans covering 48,000 retirees. She also serves as a leader in the areas of health insurance cost containment, project management, risk management and federal health care solutions. Gilbert served in management and directorship positions for a Louisville, Kentucky law firm and a cost containment company, The Rawlings Company, from 1989 through 2002. Prior to that, she worked as an accountant for a national CPA firm. Gilbert earned a bachelor’s degree in accounting from Bellarmine University in Louisville, Kentucky and is a certified public accountant and a certified government benefits administrator. She has served on the board of the State and Local Government Benefits Association and is a member of the Public Sector Healthcare Roundtable. Learn more about your ad choices. Visit megaphone.fm/adchoices
Today’s episode is the 3rd episode in my PGx for Pharmacists Podcast series entitled, “The State of the PGx Industry: Pharmacogenomics Science and Research". I am super honored that, yet another one of my pharmacogenomics science expert colleagues is joining me on the podcast to provide my audience with high quality, evidence-based pharmacogenomics content. Today’s guest just so happens to be joining me from across the world! Like many of my guests, today’s guest started his pharmacist career in what we might define as a traditional pharmacist career path and then he transitioned his career to now create and research pharmacogenomic variant cell lines in the lab. His research will eventually be translated into predictive clinical pharmacogenomics software. Featured guest: Zeyad Ibrahim MClinPharm BPS BCOP AdvPP Consultant Cancer Pharmacist and Pharmacogeneticist Learn more about your ad choices. Visit megaphone.fm/adchoices
Dr. Samit Shah serves as the Dean of the Regis University School of Pharmacy. Dr. Shah also served as the Assistant Dean and Department Chair of Biopharmaceutical Sciences at KGI SPHS. Dr. Shah earned a BS in pharmacy from North Gujarat University, a PhD in pharmaceutical sciences from the University of Missouri-Kansas City (UMKC), and an MBA from South University. He received post-doctoral training at the Massachusetts Institute of Technology (MIT). Dr. Lam received her Doctor of Pharmacy degree from the University of Southern California (USC). She completed a two-year fellowship at USC School of Pharmacy in HIV pharmacotherapy and translational research. She is credentialed by the American Academy of HIV Medicine. She is currently an Associate Professor at Chapman University School of Pharmacy. Dr. Lam currently practices in a multidisciplinary medical team treating general medicine, HIV and HIV/HCV coinfected patients with the AltaMed Medical Group in Santa Ana. Dr. Lam has also authored several book chapters and journal articles on these topics. Together with Dr. Mary Gutierrez they have written the book called Pharmacogenomics: A primary for clinicians. Now available on Amazon. Learn more about your ad choices. Visit megaphone.fm/adchoices
On this episode of the PGx for Pharmacists Podcast, Dr. Codi Peterson, a Doctor of Clinical Pharmacy and pediatric pharmacist, and discusses what was once a taboo subject for pharmacists and that is cannabis. We will explore how pharmacy has and hasn’t progressed in its acceptance of cannabis over the years, what roles Codi plays in the cannabis industry, how he has often had to make clinical decisions with limited pediatric data and how he applies the same logic to evaluate cannabinoid- based therapies. As well, we will discuss the pharmacogenomics, pharmacokinetics, and pharmacodynamics of cannabis. On This Episode We Discuss:
· Codi’s education (Brief)
· Codi’s non-cannabis PharmD work experience (Brief)
· What sparked Codi’s interest in cannabis?
· Cannabis’ mechanism of action and possible reasons why it isn’t yet a standard medication
· Codi’s PGx cannabis work experience
· PGx of Cannabis
Guest and Contact Info: Codi Peterson, PharmD, RPh pedrphphx@gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices
Amina Abubakar, PharmD, AAHIVP CEO of Avant Pharmacy & Wellness Center President of Avant Institute
Amina Abubakar graduated from the Philadelphia College of Pharmacy University of the Sciences in 2005. She is the owner and manager of Avant Pharmacy & Wellness Center formerly known as Rx Clinic Pharmacy in Charlotte, NC, and the founder of the Avant Institute.
She is an internationally recognized award-winning clinical pharmacist, Certified HIV Specialty Pharmacist, a preceptor to UNC Chapel Hill residents and students from several schools of pharmacy. Recently, Amina was bestowed the honor by the National Community Pharmacists Association as 2020’s Independent Pharmacist of the Year and also received the 2020 Bowl of Hygeia from the North Carolina Association of Pharmacists for outstanding service to the community. She has fostered an environment that showcases the impact of community pharmacists on patient care by collaborating with medical providers and expanding pharmacist-led clinical services in her community. Her desire to help others advance the pharmacy profession inspired her to found the Avant Institute to offer training to pharmacies across the country on the practical application of clinical pharmacy services through developing sustainable physician collaborations.
[Advocacy] Currently, she shares her passion for pharmacy advancements with pharmacists, patients and policy makers all over the country through Pharmacogenomics. She was invited to the White House Office of Science and Technology Policy and to the FDA to discuss the role of pharmacists in pharmacogenomics.
This episode is sponsored by the Ultiguard Safe Pack. UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy., Learn more about the UltiGuard Safe Pack: https://www.ulticare.com/ultiguard-safe-pack/podcast Learn more about your ad choices. Visit megaphone.fm/adchoices
Our special guest & newest host of the PGX for Pharmacists Podcast, Nancy Gadelsayed BS, RPh. Nancy Graduated pharmacy school from Cairo university in 2005, top %10 of her class, with 3.9 GPA She has been practicing as a pharmacist in the States since 2007, with passion for personalized medicine. She is currently a pharmacy manager at a big retail company and is also the founder and owner of Texas Pharmacogenomics Consulting LLC. And is a big advocate for pharmacists and their value in the healthcare team. She has extensive experience in retail pharmacy management and inclusive leadership . Developed and trained teams and brought on board, she leads with passion. She mentors new pharmacists/practitioners and enjoys precepting pharmacy students. Nancy found her true calling in PGx, so she founded her PGx consulting company, Texas Pharmacogenomics Consulting LLC. She believes in giving back to her community, so she volunteers at a local non-profit organization for mental health services, she develops educational materials on mental health drugs for their staff to use in their daily work routine while they are serving patients. She also helps them develop tools and procedures to assist in patients' adherence and decrease their costs of services. texaspgx.com Learn more about your ad choices. Visit megaphone.fm/adchoices
According to the American Association for Cancer Research, 80-90% of the administered dose of the cancer medication 5-fluorouracil of 5FU is degraded by the enzyme dihydropyridine dehydrogenase or DPD for short.
(https://clincancerres.aacrjournals.org/content/5/8/2006). According to the Institute of Safe Medication Practices (www.ismp.org/resources/screening-dihydropyrimidine-dehydrogenase-dpd-deficiency-fluorouracil-patients-why-not) the incidence of DPD deficiency is low like 1-7% of the population but the consequences can be unfortunately fatal for those few.
Christina Delsoldato, wife and mom of 3 beautiful children has spent most of her life laughing and loving as much as she can. Christina has built a successful professional career in hospitality, customer service and sales. Christina has faced many obstacles and traumatic events during her life. Christina took her mother’s quickly declining health into her own hands. Despite having no clinical and medical background, she spent countless nights reading, learning and researching to find answers.
These efforts and findings are what allowed her beloved mother to come home to spend her last days on earth surrounded with the love and support of her closest family. Since her mother’s diagnosis with Pancreatic Cancer and 5FU toxicity, Christina has become determined to help guide others to self-educate, research and ask questions about potential life-threatening side effects that could indeed be prevented and/or reversed.
Tragically, only three months after her mom passed away, her father died suddenly. Christina is on a mission to empathize and advocate not just for her family, but for anyone in need.
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Jamie grew up in a small town in Wyoming where she got her start in pharmacy working at the local City Drug. She attended the University of Wyoming School of Pharmacy for her Doctor of Pharmacy. For 10 years post-graduation Jamie worked in community pharmacy while having and raising her 4 little boys. However, a young family and community pharmacy work schedules are not highly compatible, so in 2020 Jamie created her own job for herself that better suits her talents, her passions, and her family’s busy schedule. She abruptly jumped out of retail and into the world of entrepreneurship and has found her true calling in life. She is the founder & CEO of Arches Health, LLC, and serves there as a precision medicine consultant pharmacist focusing on pharmacogenomics.
After getting her practice up and running she turned around and began promoting and empowering pharmacists to champion PGx and create their own consulting practices through her PGx Consulting Confidence Academy. Dr. Wilkey is a member of CPIC as well as the nonprofit organization GTMR.
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Implementing Pharmacogenomics into the Education of the PharmD
How do interested faculty start a program for PGx education at their own school?
Today’s episode builds on the experiences of David Hurley in developing a PGx program at the Gatton College of Pharmacy. His training provides ALL first year students with free PGx testing coordinated with Biochemistry coursework. As we will discuss, making a workable program starts with discovering what PGx resources are available at your institution. Careful understanding of faculty and student abilities and needs are the foundation for making PGx education successful.
Our guest today, Dr. David Hurley, has democratized Pharmacogenomics education for his first year PharmD students. As a Biochemistry professor at the Bill Gatton College of Pharmacy at East Tennessee State University, Dave immerses pharmacy students with PGx training and free testing in their first semester of the curriculum. In two previous episodes, we’ve discussed how he accomplished this task and his surveys of student attitudes and interest. Today’s episode will provide some of the lessons Dave learned about how to implement PGx education that might be useful for those of you who are starting your own program.
David L Hurley, PhD Professor, Dept of Pharmaceutical Sciences
Bill Gatton College of Pharmacy
20 Best Genomics Podcasts of 2021
https://welpmagazine.com/20-best-genomics-podcasts-of-2021/
Thank you RxSafe for sponsoring this episode
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
How can we leverage pharmacists to help patients transition better and also allow the providers use the expertise of pharmacists?
According to the peer review journal JAMA (Journal of American Medical Association), to improve care when patients transition from a facility such as a hospital to their home, Medicare started reimbursing for what is called the Transition of Care in 2013. It still has a low adoption because the reimbursement is not as high and also takes resources such as staffing.
Link to article mentioned: https://jamanetwork.com/journals/jama/fullarticle/2719292
Dr. Chinki Bhatia completed her Master of Pharmacy from University of Sydney with a specialization in in-vitro fertilization. She was then awarded a scholarship from the University of Florida to complete her Ph.D. in Neuroscience. She acquired her Ph.D. while working on multiple projects and writing her dissertation on the role of cannabinoids in short-term memory. After seeing a need for personalized medicine, Dr. Bhatia added a pharmacogenomics certification to her educational resume in 2020. She Co-Founded her company Core Care Rx where she provides pharmacogenomics consultations, value based care services such as chronic care management along with Ayurvedic wellness consultations. She also serves as a preceptor to pharmacy students in Pharmacogenomics.
Dipal Soni, PharmD, BCACP attended Ernest Mario School Of Pharmacy, Rutgers University and graduated with highest distinction. She pursued one year of pharmacy practice residency at Jersey Shore University Medical Center in NJ. During this time she worked alongside physicians in ambulatory clinics where she managed complex medications. Dr.Soni is a board certified ambulatory care pharmacist with major focus on transitions of care and counseling patents. Dr. Soni provided evidence driven recommendations and optimized pharmacotherapy. She was also a speaker in various support groups at the community hospital.
Thanks to Rx Safe for sponsoring this episode!
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Dr. Jessica Whelan has extensive experience in the mental health field and has served as a speaker and advisory board member in many areas including psychopharmacology and pharmacogenomics.
Dr. Whelan is the CEO of a national network of clinicians with Holon Inclusive Health System and adjunct faculty at Maryville University. She supports multiple universities to provide clinical mentorship for medical and nurse practitioner students. She received her Bachelor of Science in Nursing from Goldfarb School of Nursing at Barnes Jewish College in St. Louis. She received her Master of Science in Nursing from the University of Missouri Columbia and her Doctorate in Nursing Practice at the University of Missouri St. Louis.
She is brilliant in how her mind works around PGx and routinely uses personalized medicine to evaluate complex patients who have exhausted all other options of treatment. She is definitely one of the most PGx experts of all time. She had me at COMT gene!
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
ALVA10: the Power of Diagnostics
Have you ever questioned why a payer pays for a medication, yet does not pay for the diagnostic test to determine if the medication will be efficacious and non-toxic for the patient?
Or perhaps, you may have wondered why payers agree to pay for a medication for which no diagnostic test exists to diagnose the condition the medication treats?
If these types of questions keep you awake at night like they do me, please join me for this podcast episode in which I and my esteemed colleagues, Hannah Mamuszka and Lena Chaihorsky of Alva10 discuss answers to these questions and the general state of the pharmacogenomics market access and reimbursement landscape.
Lena Chaihorsky & Hannah Mamuszka join Dr. Becky Winslow to discuss diagnostic testing and the preventative savings for PGX testing for patients on multiple medications.
Episode Based on LI article written by Hannah:
https://www.linkedin.com/pulse/bigger-problem-aduhelm-we-dont-know-who-has-disease-hannah-mamuszka/?trackingId=GIb%2BLnNCys35sG19%2Fo0NFw%3D%3D
ALVA10:
https://alva10dx.com/
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Today's episode of the PGX for Pharmacists podcast is hosted by Dr. Becky Winslow, PharmD. Dr. Winslow is a pharmacogenomics authority with more than twenty years of clinical pharmacotherapy and pharmacy business operations experience, which includes seven years of direct patient facing care, seven years of pharmacy management experience and six years of experience as a medical science liaison in the pharmacogenomics field.
Dr Howard McLeod is an internationally recognized expert in precision medicine, having made novel contributions at the discovery, translation, implementation, and policy levels. He is the Medical Director for Precision Medicine at the Geriatric Oncology Consortium and a Professor at the University of South Florida Taneja College of Pharmacy. Howard received a BSPharm from University of Washington and a PharmD from the Philadelphia College of Pharmacy & Science.
Dr. McLeod completed clinical pharmacology fellowship training at St Jude Children’s Research Hospital and then the Beatson Institute, University of Glasgow. Dr McLeod has been a tenured full Professor since 2002 and involved in over $80,000,000 in peer reviewed funding.
Dr McLeod chaired the NHGRI eMERGE network external scientific panel for the past decade and was a recent member of both the FDA committee on Clinical Pharmacology and the NIH Human Genome Advisory Council. Dr McLeod has been recognized as a Fellow of both the American Society of Clinical Oncology and the American College of Clinical Pharmacy and was recently ranked #1 USA/#2 World for Pharmacogenomics. He has also been an active Board Member and/or Founder for over a dozen privately held and publicly traded companies.
Howard has published over 580 peer reviewed papers on pharmacogenomics, applied therapeutics, or clinical pharmacology and continues to work to advance innovative healthcare.
This episode of the PGX for Pharmacist podcast is sponsored by Pharmazam:
https://pharmazam.com/PPN
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
DeLon Canterbury is a Board Certified Geriatric Pharmacist. He founded GeriatRx, a telehealth-based senior care consulting company. GeriatRx combines Pharmacogenomic testing and Comprehensive Medication Management. He addresses the social determinants of health. He helps reduce medication errors and advocates for de-prescribing.
Dr. DeLon helps improve patient safety and saves patients, their families, and the healthcare system money. He manages patients across the state of North Carolina and demonstrates the value pharmacists add to healthcare delivery.
Dr. DeLon is an active Executive Board Member for the African-American Minority COVID Task Force in Durham, North Carolina, a Formulary Committee member of Senior PharmAssist at the Durham Senior Center for Life. He served as Community Health Coalition’s Telehealth Director, helping older African-American patients with wellness and reassurance check-ups during COVID.
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
PART TWO: Pharmacogenomics Education is critical to advancing the Pharmacist's optimal impact on medication management as a tool to ensure the drugs prescribed work as intended.
The State of the Industry -- Pharmacogenomics Education
Clinical pharmacogenomics activities may include designing patient-specific drug and dosage regimens based on genetic profile, documenting clinical recommendations, educating pharmacists and other health care professionals, and recommending testing
Advanced training in pharmacogenomics may open up more practice opportunities for pharmacists, such as developing clinical decision support tools in electronic health record systems that guide prescribers on appropriate drug therapy regimens based on genetic profiles. Additionally, pharmacists can develop institutional guidelines and processes for implementing clinical pharmacogenomics services into various practice settings.
Pharmacists can also develop patient education materials to explain the significance of the tests and serve as expert consultants in a pharmacogenomics service.
Special guest: David Hurley PhD.
David Hurley grew up in Dunwoody, GA, then earned a BS in Biology and Physics from Guilford College in Greensboro, NC, in 1979. He received his PhD in Molecular and Cellular Biology from Penn State University in 1986. He joined the faculty in Cell and Molecular Biology at Tulane University in New Orleans in 1992. He developed "Cellular Biochemistry" as a senior-level course for premedical students, while maintaining a research focus on the regulation of gene transcription of the Growth Hormone gene in the pituitary. Dr Hurley was an National Science Foundation CAREER program awardee from 1996-2004, and was co-investigator on a National Institutes of Health grant for 17 years. After the devastation of Hurricane Katrina, he joined the Gatton School of Pharmacy at East Tennessee State University as an inaugural faculty member in July, 2007, as Professor and Vice-Chair in the Department of Pharmaceutical Sciences. He has 45 publications, is a member of The Endocrine Society, the Society for Neuroscience, the AACP, and has been a grant reviewer for 6 years with the National Institute for Diabetes, Digestive and Kidney Diseases.
Our host: Becky Winslow, PharmD
Dr. Becky Winslow is a co-host on PGX for Pharmacists. She’s an accomplished Doctor of Clinical Pharmacy with more than twenty years of clinical pharmacotherapy and pharmacy business operations experience, which includes seven years of direct patient facing care, seven years of pharmacy management experience and six years of experience as a medical science liaison in the pharmacogenomics field. Becky Winslow excels at developing and managing collaborative relationships with healthcare professionals and key opinion leaders to stay abreast of emerging trends and to achieve project goals. Becky Winslow is an articulate communicator with extensive background in gathering and critically analyzing research and data; translating complex content into a level appropriate to the target audience; writing clinical and marketing content; presenting; teaching; and training.
This episode of the PGX for Pharmacist's podcast is brought to you by RxSafe.
Thanks RxSafe for Sponsoring this episode:
RxSafe.com
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Dr. Jai Patel, PharmD, BCOP, CPP
Chair of Department of Cancer Pharmacology & Pharmacogenomics
Dr. Jai Patel is a pharmacist who help create a pharmacogenomics fellowship which was not available at his school. He finished the Oncology/Pharmacogenomics Postdoctoral Fellowship at the UNC Eshelman School of Pharmacy.
Dr. Patel: “I approached my mentor and said, ‘this is what I want to practice. I have the ambition and drive.’ I had to convince him I was a good investment. Just because something doesn’t exist, doesn’t mean it isn’t possible. That’s what will set you apart from others when trying to build something new. Health care is always changing. Position yourself to be in the forefront of medicine.
Dr. Patel serves as Chair of the Department of Cancer Pharmacology and Pharmacogenomics at Levine Cancer Institute. He is also the associate Professor in the Division of Hematology/Oncology. Dr. Patel’s research focuses on translational and clinical pharmacogenomics and pharmacokinetics of anticancer therapies.
Behnaz Sarrami, MS, PharmD
Pharmacogenomics (PGx) coach and consultant | MSL at Atheadx
Behnaz Sarrami is the co-host to the PGx for Pharmacist Podcast. She is an expert in the field of PGx and mentor to pharmacist who are establishing their own PGx consulting business. She believes in personalizing a patient’s medication based on each individual’s genetic makeup and is keen in helping overcome barriers for both pharmacist and providers who want to implement PGx in any clinical setting.
Behnaz received her Master’s degree in Biochemistry from Georgetown University and her Doctorate in Pharmacy from Creighton University. Behnaz has been a contributor of Washington University’s Public Health blog. She also serves as a consultant for a grant-funded research project which aims to increase medication adherence in older adults who suffer from mental health.
This episode is sponsored by the Ultiguard Safe Pack. UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy.,
Learn more about the UltiGuard Safe Pack:
https://www.ulticare.com/ultiguard-safe-pack/podcast
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Pharmacogenomics Education is critical to advancing the Pharmacist's optimal impact on medication management as a tool to ensure the drugs prescribed work as intended.
The State of the Industry -- Pharmacogenomics Education
Clinical pharmacogenomics activities may include designing patient-specific drug and dosage regimens based on genetic profile, documenting clinical recommendations, educating pharmacists and other health care professionals, and recommending testing
Advanced training in pharmacogenomics may open up more practice opportunities for pharmacists, such as developing clinical decision support tools in electronic health record systems that guide prescribers on appropriate drug therapy regimens based on genetic profiles. Additionally, pharmacists can develop institutional guidelines and processes for implementing clinical pharmacogenomics services into various practice settings.
Pharmacists can also develop patient education materials to explain the significance of the tests and serve as expert consultants in a pharmacogenomics service.
Special guest: David Hurley PhD.
David Hurley grew up in Dunwoody, GA, then earned a BS in Biology and Physics from Guilford College in Greensboro, NC, in 1979. He received his PhD in Molecular and Cellular Biology from Penn State University in 1986. He joined the faculty in Cell and Molecular Biology at Tulane University in New Orleans in 1992. He developed "Cellular Biochemistry" as a senior-level course for premedical students, while maintaining a research focus on the regulation of gene transcription of the Growth Hormone gene in the pituitary. Dr Hurley was an National Science Foundation CAREER program awardee from 1996-2004, and was co-investigator on a National Institutes of Health grant for 17 years. After the devastation of Hurricane Katrina, he joined the Gatton School of Pharmacy at East Tennessee State University as an inaugural faculty member in July, 2007, as Professor and Vice-Chair in the Department of Pharmaceutical Sciences. He has 45 publications, is a member of The Endocrine Society, the Society for Neuroscience, the AACP, and has been a grant reviewer for 6 years with the National Institute for Diabetes, Digestive and Kidney Diseases.
Our host: Becky Winslow, PharmD
Dr. Becky Winslow is a co-host on PGX for Pharmacists. She’s an accomplished Doctor of Clinical Pharmacy with more than twenty years of clinical pharmacotherapy and pharmacy business operations experience, which includes seven years of direct patient facing care, seven years of pharmacy management experience and six years of experience as a medical science liaison in the pharmacogenomics field. Becky Winslow excels at developing and managing collaborative relationships with healthcare professionals and key opinion leaders to stay abreast of emerging trends and to achieve project goals. Becky Winslow is an articulate communicator with extensive background in gathering and critically analyzing research and data; translating complex content into a level appropriate to the target audience; writing clinical and marketing content; presenting; teaching; and training.
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Behnaz Sarrami, MS, PharmD, a PGx for pharmacists podcast, joins Cari Lalande, PharmD where we discuss the clinical value and utility of PGx and how it can be implemented in a clinical setting.
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Behnaz Sarrami, MS, PharmD, a PGx for pharmacists podcast, Maci Koesterer, PharmD candidate 2021 from St. Louis College of Pharmacy where we discuss her first virtual and unique rotation in PGx and her recommendations to other students.
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Behnaz Sarrami, MS, PharmD, an entrepreneur and a coach in PGx who has started her own consulting business bringing awareness to the clinical value and utility of PGx to providers, pharmacists, and consumers.
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Kristine Ashcraft, BS, MBA is a molecular biologist by training and is the former CEO and founder of YouScript, recently acquired by Invitae. She has worked in pharmacogenomics since 2000 and was recently named one of the 25 leading voices in precision medicine. Kristine has authored multiple publications on the clinical and economic benefits of pharmacogenomic testing including one lauded as one of the most influential publications at an American Medical Informatics Association meeting.
Kristine has been interviewed by numerous media outlets including the New York Times, the Wall Street Journal, and NBC Nightly News and has spoken at SXSW, American Society of Human Genetics, and numerous precision medicine conferences. She is committed to catalyzing the adoption of precision medicine.
For all the PGX for Pharmacists episodes, please visit: PGX4RX.com
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Becky Winslow PharmD, of PGX for Pharmacists podcast, joins Eric Geyer PharmD in this mash-up 'Pharmacy Podcast' hybrid episode where we discuss not only the Plavix case but several other cases where pharmacogenomics could help make a huge difference in our healthcare system, including in how we treat opioid addiction.
Hawaii recently fined Bristol Myers Squibb and Sanofi under consumer protection standards for their drug Plavix (clopidogrel). This could be a game changing case due to the fact that it could have been prevented with more studies using pharmacogenomics.
Special insert from KHON2 News with Hawaii Attorney General Clare Connors held a news conference on Tuesday to discuss the million-dollar lawsuit against Bristol-Myers Squibb Co. and Sanofi.
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Becky Winslow, PharmD & Pharmacy Student Kaitlyn Marshall re-launch the PGX for Pharmacists.
23andMe announced in August of 2020 that it has received a 510(k) clearance from the FDA that allows its direct-to-consumer personal pharmacogenetics report to guide use of two treatments without the need for confirmatory testing.
This action updates a De Novo approval granted to the consumer genomics company in late 2018. That decision allowed 23andMe to market a test for one of 33 variants across multiple genes that could impact metabolization of certain medication, but came with a handful of "special controls." Among these were labeling requirements that warned consumers not to use the product for any medication decisions without additional independent testing.
Guests: Becky Winslow, BS, PharmD - Medical Affairs
Dr. Becky Winslow, earned both her Bachelors of Science in Biology and her doctorate in clinical pharmacy from Campbell University. She earned her Test2Learn(TM) Community-Based Pharmacogenomics Certificate, as well as, her "Train the Trainer" certification through NACDS and The University of Pittsburgh School of Pharmacy.
Dr. Winslow brings over 20 years experience building clinical pharmacy programs, as well as, directing pharmacy business operations in the community setting to inGENEiosu RX. She has patient facing clinical experience as a pharmacist in retail, hospital, public health, and long term care pharmacies. Dr. Winslow founded and has owned her general pharmacy consulting business for over 20 years. In the last 6 years, she has specialized in pharmacogenomics consulting.
Dr. Winslow's professional associations include being a member of the Clinical Pharmacogenetics Implementation Consortium and The Get the Medications Right Institute.
Now recognized as a community pharmacogenomics subject matter expert, Dr. Winslow is sought after to create and present original pharmacogenomics content and to consult for pharmacogenomics industry vendors and the clients they serve. Kaitlyn Marshall - PharmD Candidate 2021
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Dr Sanjeda Chumki, PharmD talks with Ken Sternfeld, host of PGX for Pharmacists about Admera Health and the power of pharmacogenomics in the hands of the clinical pharmacist.
About Admera Health:
Admera Health is an advanced molecular diagnostics company focused on personalized medicine, non-invasive cancer testing and digital health.
Dedicated to developing cutting-edge diagnostics that span the continuum of care, Admera Health fulfills unmet medical needs with cost-effective tests and accurate analysis to guide patient care. Utilizing next generation technology platforms and advanced bioinformatics, Admera Health seeks to redefine disease screening, diagnosis, treatment, monitoring, and management through its innovative, personalized solutions.
It is our mission to deliver transformative, valuable solutions for patients, physicians, and clinical researchers. We are committed to improving the health and well-being of our global community through the direct delivery of personalized, medically actionable results.
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Ken Sternfeld, RPh., host of PGX for Pharmacists
interviews CARLA DELLAPORTA with NeedyMeds.
Mission Statement: NeedyMeds educates and empowers those seeking affordable healthcare.
Find help with the cost of medicine.
Vision Statement: Our vision is affordable healthcare for all.
How we do it: NeedyMeds, a national non-profit, achieves its mission by providing information on healthcare programs, offering direct assistance and facilitating programs.
NeedyMeds is funded by small grants, donations, sponsorships, subscriptions to PAPTracker, and syndication of some of our database information. NeedyMeds also works with the patient assistance programs of several pharmaceutical distributors.
CARLA DELLAPORTA Director of Education & Partnerships NeedyMeds Email: carla@needymeds.org PO Box 219, Gloucester, MA 01931 978-281-6666 Business 800-503-6897 Helpline https://www.needymeds.org/
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
PGX for Pharmacists host, Ken Sternfeld, RPh., interviews the dynamic crew from Medipreneurs about changing the status-quo of Pharmacy.
If you’re someone who recognizes that healthcare is changing and even have some creative new ideas to introduce to the world of pharmacy, then we welcome you with open arms.
We are three smart, fierce, and pretty quirky pharmacists who chose to get out of the box, become entrepreneurs, and find freedom by starting our own businesses. This allowed us to pursue our passions, and approach health care holistically with the focus where it should be – on the patient.
The three of us joined forces to help each other through the journey from traditional pharmacist to business owner and from this we have seen the good, the bad, and the ugly along the way. We spent years working to create business models and systems that work; to understand the marketing strategies necessary for growth; and to grow our highly successful businesses.
We made a choice to forge new paths in healthcare, and take back the power to heal that a pharmacist should have. Although we’re each following our own unique passion, we are united in our purpose: To give other medical professionals the tools to do things differently and join us as leaders in this new movement in pharmacy.
We work and network with many pharmacy entrepreneurs and INTRApreneurs, and we are witnesses to how THESE are the pharmacists who are not only finding true autonomy and are able to provide real patient-centered care, as they should be, but they’re also finding greater financial success doing so. Sue Paul - LinkedIn: www.linkedin.com/in/sue-paulrph Michelle Fritsch -LinkedIn: https://www.linkedin.com/in/michelle-fritsch-6462bbb/ Anna Garrett - LinkedIn: https://www.linkedin.com/in/annagarrett?
The 2nd Medipreneurs Summit will be held in Asheville, NC on April 26-28, 2019. Early-bird registration is now open and limited to 50 tickets. Event details and registration are at www.medipreneurs.com. Want to hear what last year's participants had to say? Click here to watch this video: https://youtu.be/T1jhR6WjyeU Here is the Medipreneurs Facebook link: https://www.facebook.com/medipreneurssummit/ CONTACT:
Dr. Jason Cavolina BS, PharmD, MS, RPhi
President and CEO
p: 1.844.MYRXVIP m: 631.871.4400 f: 516.200.3834
a: 1299 Corporate Drive Suite 1504, Westbury, NY 11590
w: www.rxvipconcierge.com
e: Jason@rxvipconcierge.com
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
PGX for Pharmacist host Ken Sternfeld, RPh., interviews (long time anticipated guest) Dr. Eboni I. Green.
Eboni is a Registered Nurse and family caregiver. She holds a Ph.D. in human services, with a specialization in health care administration. She and her husband are cofounders of Caregiver Support Services, a nonprofit organization that offers training and consulting for family caregivers and front-line direct caregivers. In addition, she currently serves as contributing faculty for the College of Health Sciences at more than one university, where she teaches graduate courses in the health care administration program.
Green has extensive experience focused on caregivers’ health and wellness, with an emphasis on caregiver stress, burnout, and related family conflicts. In 2002, she became the Nebraska State Representative for the Caregiver Acton Network. Most recently, she was appointed as chair elect on the Forum on Spirituality and Aging, the largest constituent group for the American Society on Aging. Green has contributed to a number of publications and given presentations that focus on training, assessing, and supporting caregivers throughout the caregiving journey. Green is a published author and has written two books focusing on family caregiving: At the Heart of the Matter and Caregiving in the New Millennium, and has a third book Reflections from the Soul that will be released in 2016.
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
PGX for Pharmacists host Ken Sternfeld, RPh., talks with one of the original physicians he began working with on Pharmacogenomics testing for patient's better health.
About Dr. Michael Goodman
Dr. Goodman notes: "As a board-certified internist and your personal physician, helping you achieve your optimal health is my priority. I will establish a close partnership with you and help guide you toward the most innovative steps in modern healthcare. Beyond the personalized wellness program and customized action plan offered in my MDVIP-affiliated primary care practice, my patients enjoy many conveniences not found in most medical offices today. I am available 24/7 on my cell phone, you will be seen promptly for all visits, as your time is valuable, and I will help coordinate your care with specialists. As a private internal medicine doctor, I am knowledgeable in all aspects of adult medicine – cardiology, endocrinology, pulmonary medicine - to name a few. And I've been recognized a “Top Doctor” by Castle Connolly. I have been board certified in internal medicine since 1980 and have practiced in the Merrick and Bellmore areas of New York for 30 years. My office is in Bellemore, south of Southern State Parkway, Sunrise Highway, Merrick Road and near major highways. I have established relationships with many specialists in the community and at the leading hospitals in Nassau County, Suffolk County and New York City and am affiliated with South Nassau Communities Hospital. Being healthy is a choice. As a member in my personalized healthcare practice, sometimes referred to as a concierge medical practice, you will be making an investment in your health that is the best prescription now and in the future. Please call my office anytime to discuss your healthcare needs. I participate in most major health insurance plans and am fluent in Italian, Internet, iPad and iPhone."
https://www.mdvip.com/doctors/michaelgoodmanmd
For more information about how to build your PGX Business, contact:
Dr. Jason Cavolina BS, PharmD, MS, RPhi
President and CEO
p: 1.844.MYRXVIP
a: 1299 Corporate Drive Suite 1504, Westbury, NY 11590
w: www.rxvipconcierge.com
e: Jason@rxvipconcierge.com
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Today's PGX for Pharmacist episode discusses the STAAR ALERT ADVANTAGE:
Beyond cutting edge technology, stability and competitive pricing, STAAR Alert offers a level of personalized service far above that of most others in the market.
STAAR Alert offers communication and Electronic Health Record (EHR) integration through our Life Safety Monitoring Center’s enhanced software platform. Each form of STAAR Alert’s in-home medical device technologies offer an advanced level of professional monitoring. Signals from each device are automatically sent to the servers and CSAA professional operators at STAARAlert's Life Safety Monitoring Center, ensuring that all notifications are managed in real-time.
STAAR Alert's mission is to provide access to help in the event of an emergency, prevent medication errors and provide technology to monitor and track your health.
Contact:
Ken Sternfeld - RX VIP Concierge Founder, Director New Business Development 1299 Corporate Drive Suite #1504 Westbury, New York 11590 516 817-7410ken@rxvipconcierge.com
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
PGX for Pharmacists host Ken Sternfeld, RPh., talks with Matthew Krzywosz, PharmD Partnerships Marketing Manager at Antidote.
Antidote is a digital health company on a mission. Their aim is to accelerate breakthroughs in potentially life-saving treatments by bridging the gap between medical research and the people who need it. In a world where 80% of clinical trials are delayed or closed due to a lack of patients taking part, Antidote uses cutting-edge technology to match the right patients with the right trials. Antidote is helping medical researchers make progress – so that new treatment options can make it to patients, faster.
Contact Ken via Email: ken@rxvipconcierge.com
Phone: 1-844-MYRXVIP (1-844-698-9847)
Matthew Krzywosz, PharmD
Antidote Partnerships Marketing Manager E matthew@antidote.me
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Hillary Blackburn, PharmD is the Director of Pharmaceutical Services at Dispensary of Hope. In this role, she is responsible for providing clinical pharmacist expertise to support the organization as well as its network of pharmacies and charitable clinics.
As the Director of Pharmaceutical Services, Hillary consults with pharmacy leaders across the country, sharing expertise on affordable medication access for low income patients. Her work with health systems include strategy development for identifying and implementing programs to address gaps in pharmaceutical care including the Dispensary of Hope program.
In addition, Hillary collaborates in the development and use of the formulary and tools for successful program utilization by the pharmacies and charitable clinics in the Dispensary of Hope network. Hillary is a graduate of the University of Mississippi School of Pharmacy and completed a PGY1 Pharmacy Practice Residency at the University of Mississippi Medical Center. During pharmacy school, she interned at Health Resources and Services Administration’s (HRSA) Office of Pharmacy Affairs where Hillary gained knowledge about the 340B Drug Program and developed content for HRSA’s Patient Safety and Clinical Pharmacy Services Collaborative.
Hillary is a clinically trained pharmacist with client relationship, formulary management, specialty mail order pharmacy, retail, and health plan experience. She is licensed in 11 states and serves as a preceptor for Belmont and Lipscomb Schools of Pharmacy.
Contact Hillary Blackburn, PharmD
hillary@pharmacyadvisory.com
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
PGX for Pharmacist's Co-Host Ken Sternfeld RPh., interviews David Kisor, PharmD., Director of Pharmacogenomics Education at Manchester University. Manchester University Master of Science in Pharmacogenomics: http://www.manchester.edu/pgx Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines: https://cpicpgx.org/guidelines/ Genetics/Genomics Competency Center - Pharmacists Competencies: http://genomicseducation.net/competency Pharmacogenomics Competencies in Pharmacy Practice: A Blueprint for Change https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373920/
Dr. Jason Cavolina BS, PharmD, MS, RPhi
President and CEO
p: 1.844.MYRXVIP m: 631.871.4400 f: 516.200.3834
a: 1299 Corporate Drive Suite 1504, Westbury, NY 11590
w: www.rxvipconcierge.com
e: jason@rxvipconcierge.com
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Special guest today:
Robert Rupard
CEO Pro-GeneX, LLC "Assisting Personalized Healthcare" On LinkedIn: www.linkedin.com/in/robertrupard The Advanced Technology Development Center at Georgia Tech 75 5th Street Suite 200 Atlanta, GA 30308 Toll Free: (844) 794.3637 ext. 101 Mobile:(770) 530.4279 Direct: (404) 419-7915 Fax: (678)807-2826 Please "Like" our Facebook Page at: facebook.com/Pr0GeneX
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
On this episode of PGX for Pharmacists, host Ken Sternfled, RPh., interviews Dr. Jason Cavolina PharmD, CEO of RXVIP Enterprises.
Jason is part of a group of Pharmacists and Students of Pharmacy who took on a personal mission to raise awareness and deliver a 2 minute life saving test.
This life saving test can help reduce the risk of Adverse Drug Reactions (ADRs). These tests have been around for over 9 years and are now covered by Medicare so we are raising awareness through a national alliance we formed with MedXPrime. -Offering PGx tests will further differentiate our companies as the leader in the market by delivering 'Tomorrow's Medicine Today'. - We can offer valued based services that include consultation, screening and also perform the test to create incremental revenue, even after the initial visit with the patient with no change in workflow or added expense. -This initiative also positions RXVIP as a leader in reducing adverse drug reactions in patients through pharmacogenetic testing (PGx). -This will also help create additional engagement to help retain medicare patients that can create ongoing reimbursement for the practice. RXVIP would be happy to sponsor patient events to 'Meet The Pharmacist' to patient education by trained pharmacy staff at no cost to a practice. RXVIP Concierge Pharmacists meet with patients directly in a doctor’s office to conduct Pharmacogenetic testing (PGx), educate patients on cost-saving solutions and to encourage lifestyle changes, while focusing on patient adherence to medication regimens in order to achieve better outcomes. Our single goal is to help patients and their physicians navigate the challenging and evolving health care landscape now in place with insurance entities, including assisting staff with prior authorizations and ePrescribing. Areas of Expertise: Concierge Pharmacy, PGx, Business Development, Team Management, Inventory Optimization, Marketing, Process Implementation, Strategic Planning & Analysis, Quality and Process Control, Workflow Optimization, Leadership, Project Management
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
About the Pharmacy Podcast Network:
In 2009 Todd S. Eury launched the pharmacy industry’s first podcast about the Business of Pharmacy dedicated to pharmacist professionals called the ‘Pharmacy Podcast Show’.
In 2011, Eury's podcast evolved and in the fall of 2014, several pharmacists joined the podcast publication and the Pharmacy Podcast Show was transformed into the Pharmacy Podcast Network.
As a podcasting 1st in history, the audio-blog publication is the U.S. Healthcare System’s largest network of podcasts dedicated to the profession of pharmacy with 23 co-hosts developing content for 15 different podcasts segmented on different topics like healthcare law, technology, medical cannabis, senior care, and pharmacogenomics.
The Pharmacy Podcast Network has a collective listener base of about 67,000 and has personalized podcast publications for national associations like the American Society of Consultant Pharmacists and the National Association of Specialty Pharmacy.
We embed the podcasts into our sponsors web-environments or they can set up a new page on their site dedicated to the podcasts.
Be sure to see our series sponsor's landing pages:
McKesson Technologies: https://marketing.mckesson.com/2017-MPTS-Pharmacy-Podcast-Series.html
Cardinal Health: http://pharmacypodcast.com/podcast_tags/cardinal-health/
H. D. Smith: https://www.hdsmith.com/news-events/podcasts
CVS Health: http://pharmacypodcast.com/podcast_tags/cvs-health/
Majority of our podcast episodes are between 17-25 minutes (purposely for the average commute)
With 25 leading co-hosts for 15+ different podcast segments, the PPN develops new content daily for our corporate sponsors including CVS Health, McKesson, Cardinal Health, RxSafe, KeyCentrix, R.J. Hedges & Associates, ASCP, and the NASP. The folllowing podcasts are part of the PPN: https://soundcloud.com/pharmacy-podcast/sets
Pharmacy Leaders
Pharming Your Career
the Medical PotCast
the Gavel & Pestle Podcast
Specialty Pharmacy Podcast in collaboration w/ the NASP
SenioRx Radio in collaboration w/ the ASCP
the Fit Pharmacist
Pharmacy Inspection Podcast
PolitiTalkRx
PGX for Pharmacists
Pharming Your Career Pharmacy Compliance Guide
the Nontraditional Pharmacist
Income Outcomes Show
Pharmacy Future Leaders
Pharmacy Technician Podcast
Please take a look at our co-host intelligence source here, you should be part of this team:
http://pharmacypodcast.com/cohost/
Sincerest thanks to our Listeners & Sponsors,
Thank you.
Todd S. Eury - Founder | Publisher
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
PGX for Pharmacists host Ken Sternfeld RPh., returns talking about pharmacists leading the way to a new execution of better medicine and transforming from a transactional pharmacist to a 'Concierge Pharmacist'
Episode One: HERE
Integrating pharmacogenomics into pharmacy practice via medication therapy management
https://www.pharmacist.com/sites/default/files/files/mtm_integrating_pharmacogenomics.pdf
PGX Current Events: Manchester University will begin their new Pharmacogenomics or PGx online master’s program. This is the only online master’s program of its kind in the world and it was created here in Fort Wayne. http://wboi.org/post/manchesters-offers-unique-online-pharmacy-course#stream/0 Pharmacogenomics enables health care providers to tailor treatment based on genetics https://www.postbulletin.com/life/health/pharmacogenomics-enables-health-care-providers-to-tailor-treatment-based-on/article_fa5c0fd0-9fc7-52aa-9778-c643e4a959c0.html New genetic test can predict adverse reactions to epilepsy drug https://medicalxpress.com/news/2018-01-genetic-adverse-reactions-epilepsy-drug.html
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Ken Sternfeld, RPh, Concierge Pharmacist is the co-host of the new “PGx for Pharmacists” segment of the Pharmacy Podcast Network focusing on how Pharmacists, PharmDs and Students of Pharmacy can incorporate Pharmacogenetic (PGx) Testing into Care Coordination and Chronic Care Management Medication Services.
Ken is the Founder of RXVIP Concierge, a network of Concierge Care Providers (CSP) who work collaboratively with physicians and other health providers, right in their offices to deliver value-based services at the Point of Care that include Wellness Prescription CheckUps and ongoing Chronic Care Management for patients to keep them on a path to better health. www.rxvipconcierge.com
Ken is a national spokesperson for Caregiver Support Services (CSS) a “grassroot” non-profit organization with a 501 (c )(3) tax exempt status to help raise awareness to the fact that over 125,000 patients died as a result of experiencing an Adverse Drug Reaction to their medications. The organization was founded by Terrence and Eboni Green, a husband and wife team in the medical profession, to support family & professional caregivers across the lifespan through direct supportive services.www.caregiversupportservices.com
Ken has been featured in Pharmacy Today as Provider of the Month as well as being interviewed for several Pharmacy Times articles over the years as the RXVIP Concierge Pharmacist model has evolved. Ken is a member of APHA and sits on several committees plus is a member of PSSNY, as an advocate for independent pharmacy owners. Ken also mentors PharmD candidates as preceptor for several Colleges of Pharmacy & Universities Over the years as a Pharmacist at CVS Health, Ken won prestigious Paragon Award, two years in a row, plus was selected for their management Emerging Leader program. He earned his B.S. in Pharmacy from St Johns University, graduating in 1979 when he became licensed RPh in New York.
Contact Ken via Email: ken@rxvipconcierge.com
Phone: 1-844-MYRXVIP (1-844-698-9847)
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices
Pharmacy Podcast Network Blair Thielemier, PharmD interviews Clay Bullard, President of PGx Medical.
The PGx Medical team works alongside clinicians to help determine the right drug, the right dose, for the right person through their pharmacogenetic program, making it simple for physicians, pharmacists and healthcare professionals to incorporate personalized medicine into their patient care. This test guides providers in making actionable clinical decisions by optimizing patient medications.
PGx Medical believes you will lower healthcare costs, increase clinical efficiencies all while improving patient quality of life.
Clay Bullard, PresidentPGx Medical
Corporate Office:
3917A E. Memorial Road
Edmond, OK 73013
Phone: 405-509-5112
Email: info@pgxmed.com
See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices